MTOR and urinary bladder cancer: We demonstrated that in comparison with bladder cancer urothelial cells, hAM homogenate slightly increased the protein levels of PI3K p110α, mTOR and the amount of phosphorylated Akt and mTOR expression (Fig. 7A,D).